CLDX Celldex Therapeutics Inc Net earnings per share growth forecast for next year
Celldex Therapeutics (CLDX) develops unique mast cell modulators for the treatment of allergies. The historical trend of next year's EPS forecast illustrates the success of this ecosystem, where 2.30 is recorded as the baseline value. Partners' production capacities are being modernized to manufacture antibodies. Meanwhile, patent protection and the capital intensity of development create high barriers to entry for new market participants.
Metric breakdowns and analytics for celldex.com (CLDX)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Celldex Therapeutics|CLDX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Celldex Therapeutics, Inc.|CLDX - Company Debts|Debt to Book Capitalization Ratio Celldex Therapeutics|CLDX - Company Long-Term Debt|Company Short-Term Debts Celldex Therapeutics|Quick Ratio celldex.com
- earnings and valuation multiples information:
CLDX - Company Net Income|Future Profit Celldex Therapeutics|CLDX - Price to Earnings Multiple|Projected Price to Earnings Celldex Therapeutics|CLDX - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Celldex Therapeutics|CLDX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Celldex Therapeutics|CLDX - Earnings per share for the trailing year|Quarterly EPS earnings growth celldex.com|CLDX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Celldex Therapeutics
Summary company analysis:CLDX, Celldex
For Celldex Therapeutics (CLDX), whose success depends on scientific reports rather than economic cycles, this metric measures the expected percentage growth of earnings per share (EPS) for the coming year. By analyzing the EPS growth forecast trend on the GURU.Markets platform, an investor assesses the company's capitalization potential, which is critical when planning future secondary equity offerings.
Key competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Grifols Biemat (GRFS) - Expected earnings per share growth for next year|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year auriniapharma.com (AUPH)|Net earnings per share growth forecast for next year BioCryst Pharmaceuticals|Net earnings per share growth forecast for next year VERA|Net earnings per share growth forecast for next year Dianthus Pharma (DNTH)|Net earnings per share growth forecast for next year PHVS (Pharvaris Pharma)|Earnings growth forecast for next year ABCL (AbCellera Biologics)|TRML: Projected earnings per share growth rate for next year|Precigen - Earnings growth forecast for next year|Expected net earnings per share growth next year Pharming Group NV|NKTR (Nektar) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year UPB|Expected earnings per share growth for next year ZBIO|IMNM: Expected earnings per share trend next year|Expected earnings per share growth for next year GOSS (Gossamer Bio)|Projected earnings per share increase next year KALV|Earnings growth forecast for next year SEPN (Septerna Corp)|Expected earnings per share trend next year PVLA|Savara Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year rigel.com|AnaptysBio (ANAB) - Net earnings per share growth forecast for next year|Astria Therapeutics Inc - Expected earnings per share trend next year|ENGN (enGene Bio) - Earnings growth forecast for next year|Earnings growth forecast for next year RAPT Therapeutics Inc.|Net earnings per share growth forecast for next year Aerovate Therapeutics Inc (JBIO)|ACRS: Net earnings per share change forecast for next year|Earnings growth forecast for next year KYTX (Kyverna Therapeutics, Inc.)|Tiziana Life Sciences Ltd. (TLSA) - Expected net earnings per share growth next year|CABA: Expected earnings per share growth for next year|VTYX - Earnings growth forecast for next year|THTX (Theratechnologies Inc.) - Expected earnings per share growth for next year|AVTX: Projected earnings per share increase next year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Agenus, Inc. (AGEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year CLYM|Expected earnings per share growth for next year Zura Bio Ltd ZURA|Net earnings per share growth forecast for next year aTyr Pharma, Inc. ATYR|Consensus forecast of earnings per share growth for next year Adagene Inc (ADAG)|Ikena Oncology, Inc. - Earnings growth forecast for next year|Shattuck Labs, Inc. (STTK) - Expected earnings per share growth for next year|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|CNTB (Connect Biopharma Holdings Limited) - Net earnings per share growth forecast for next year|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATRA (Atara Biotherapeutics Inc)|Expected earnings per share growth for next year IFRX (InflaRx N.V.)|X4 Pharmaceuticals Inc. - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|CELU (Celularity Inc) - Net earnings per share change forecast for next year|INmune Bio, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year BRNS (barinthusbio.com)|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|ENLV: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Q32 Bio Inc. (QTTB)|Expected earnings per share growth for next year geovax.com GOVX|Earnings growth forecast for next year EDSA (Edesa Biotech)|Earnings growth forecast for next year iBio Inc IBIO|CARM: Expected earnings per share growth for next year|Expected earnings per share trend next year XTLB (XTL Bio)|BOLT: Earnings growth forecast for next year|HCWB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Net earnings per share growth forecast for next year Aditxt (ADTX)|Expected earnings per share growth for next year GRI Bio Corporation GRI|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year reshapelifesciences.com HIND|REVB - Net earnings per share growth forecast for next year|INDP (Indaptus Therapeutics Inc) - Projected earnings per share growth rate for next year|SCNI: Earnings growth forecast for next year|Expected net earnings per share growth next year CalciMedica (CALI)|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected earnings per share growth for next year Allakos Therapeutics (ALLK)|Earnings growth forecast for next year HOOK|IGMS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year iTeos ITOS|Ocean Biomedical Corp - Net earnings per share growth forecast for next year|TCBP - Net earnings per share growth forecast for next year|THRD: Net earnings per share growth forecast for next year
